Related Experiment Video
Updated: Jun 16, 2026
Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
The development of xenograft glioblastoma implants in nude mice brain
F M Brehar1, A V Ciurea, Mihaela Chivu
1Emergency Clinical Hospital "Bagdasar-Arseni, Berceni Street 10-12, Bucharest, Romania. felixbrehar@yahoo.com
Abstract:
The inefficacity of the actual therapies for glioblastoma multiformis stimulates the researchers to search for new and innovative therapies. Therefore, the development of in vivo model for glioblastoma is an essential step during these researches, being a link between cells cultures studies and the first phases of clinical trials. In this paper, we present several procedures which have been performed for the first time in our country, such as: the cultivation and manipulation of U87MG line, the manipulation of athymic knock-out mice (NUDE Crl: CD-1 Foxn 1), the stereotactic inoculation of glioblastoma cells and finally the development of glioblastoma xenograft in the brain of inoculated nude mice. These results, which offer to the researchers from our country an in vivo model for glioblastoma, could be the start point for several projects oriented to the development of new therapies in glioblastoma, and could raise the performance of our scientific research to the European level.
Insights
Researchers developed a novel in vivo glioblastoma model using U87MG cells in nude mice. This essential research tool bridges cell culture studies and clinical trials for new glioblastoma multiforme therapies.
Area of Science:
- Oncology
- Preclinical Research
- Animal Models
Background:
- Glioblastoma multiforme (GBM) presents significant therapeutic challenges due to treatment inefficacy.
- The development of robust in vivo models is crucial for advancing GBM research, bridging in vitro findings and clinical applications.
Purpose of the Study:
- To establish a novel in vivo glioblastoma xenograft model in immunocompromised mice.
- To provide researchers with a viable preclinical platform for testing new GBM therapies.
Main Methods:
- Cultivation and manipulation of the U87MG glioblastoma cell line.
- Utilization of athymic nude mice (NUDE Crl: CD-1 Foxn 1).
- Stereotactic inoculation of glioblastoma cells and subsequent xenograft development in the mouse brain.
Main Results:
- Successful establishment of a glioblastoma xenograft model in the brains of nude mice.
- Demonstration of key procedures for in vivo GBM research, performed nationally for the first time.
Conclusions:
- The developed in vivo model offers a critical resource for GBM research in the country.
- This platform is expected to stimulate new therapeutic development projects and enhance scientific research to European standards.
